Abstract
Sonodynamic therapy (SDT) represents an emerging approach that offers the possibility of non-invasively eradicating solid tumors in a site-directed manner. It involves the sensitization of target tissues with a non-toxic sensitizing chemical agent and subsequent exposure of the sensitized tissues to relatively low-intensity ultrasound. Essentially, both aspects (the sensitization and ultrasound exposure) are harmless, and cytotoxic events occur when both are combined. Due to the significant depth that ultrasound penetrates tissue, the approach provides an advantage over similar alternative approaches, such as photodynamic therapy (PDT), in which less penetrating light is employed to provide the cytotoxic effect in sensitized tissues. This suggests that sonodynamic therapy may find wider clinical application, particularly for the non-invasive treatment of less accessible lesions. Early SDT-based approaches employed many of the sensitizers used in PDT, although the manner in which ultrasound activates the sensitizer differs from activation events in PDT. Here we will review the currently accepted mechanisms by which ultrasound activates sensitizers to elicit cytotoxic effects. In addition, we will explore the breath of evidence from in-vitro and in-vivo SDT-based studies, providing the reader with an insight into the therapeutic potential offered by SDT in the treatment of cancer.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bhatnagar S, Schiffter H, Coussios CC (2014) Exploitation of acoustic cavitation-induced microstreaming to enhance molecular transport. J Pharm Sci 103:1903–1912
Bianchi PP, Petz W, Luca F, Biffi R, Spinoglio G, Montorsi M (2014) Laparoscopic and robotic total mesorectal excision in the treatment of rectal cancer. Brief review and personal remarks. Front Oncol 4:98
Byun KT, Kim KY, Kwak HY (2005) Sonoluminescence characteristics from micron and submicron bubbles. J Korean Phys Soc 47:1010–1022
Castano AP, Mroz P, Hamblin MR (2006) Photodynamic therapy and anti-tumour immunity. Nat Rev Cancer 6:35–545
Chu KF, Dupuy DE (2014) Thermal ablation of tumours: biological mechanisms and advances in therapy. Nat Rev Cancer 14:199–208
Ding C, Da Xing D (2006) Studies on the sonosensitization mechanism of ultrasound with ATX-70 in sonodynamic therapy. Life Sci J 3:85–89
Dolmans DEJGJ, Kadambi A, Hill JS, Flores KR, Gerber JN, Walker JP, Borel Rinkes IH, Jain RK, Fukumura D (2002) Targeting tumor vasculature and cancer cells in orthotopic breast tumor by fractionated dosing photodynamic therapy. Cancer Res 2:4289–4294
Dougherty TJ, Grindley GB, Fiel R, Weishaupt KR, Boyle DG (1975) Photoradiation therapy. II. Cure of animal tumors with hematoporphyrin and light. J Natl Cancer Inst 55:115–121
Fabi A, Mottolese M, Segatto O (2014) Therapeutic targeting of ERBB2 in breast cancer: understanding resistance in the laboratory and combating it in the clinic. J Mol Med 92:681–695
Feril LB, Kondo T, Cui ZG, Tabuchi Y, Zhao QL, Ando H, Misaki T, Yoshikawa H, Umemura S (2005) Apoptosis induced by the sonomechanical effects of low intensity pulsed ultrasound in a human leukemia cell line. Cancer Lett 221:145–152
Fukuzumi S, Ohkubo K, Zheng X, Chen Y, Pandley RK, Zhan R, Kadish KM (2008) Metal bacteriochlorins which act as dual singlet oxygen and superoxide generators. J Phys Chem B 6:2733–2746
Gaitan DF, Crum LA, Church CC, Roy RA (1992) Sonoluminescence and bubble dynamics for a single, stable, cavitation bubble. J Acoust Soc Am 91:3166–3183
Guo S, Sun X, Cheng J, Xu H, Dan J, Shen J, Zhou Q, Zhang Y, Meng L, Cao W, Tian Y (2013) Apoptosis of THP-1 macrophages induced by protoporphyrin IX-mediated sonodynamic therapy. Int J Nanomedicine 8:2239–2246
Hachimine K, Shibaguchi H, Kuroki M, Yamada H, Kinugasa T, Nakae Y, Asano R, Sakata I, Yamashita Y, Shirakusa T, Kuroki M (2007) Sonodynamic therapy of cancer using a novel porphyrin derivative, DCPH-P-Na(I), which is devoid of photosensitivity. Cancer Sci 98:916–920
He Y, Xing D, Tan S, Tang Y, Ueda K (2002) In vivo sonoluminescence imaging with the assistance of FCLA. Phys Med Biol 47:1535–1541
Heldin CH, Rubin K, Pietras K, Ostman A (2004) High interstitial fluid pressure – an obstacle in cancer therapy. Nat Rev Cancer 4:806–813
Herrera FG, Santa Cruz O, Achtari C, Bourhis J, Ozsahin M (2014) Long-term outcome and late side effects in endometrial cancer patients treated with surgery and postoperative radiation therapy. Ann Surg Oncol 21:2390–2397
Hiraoka W, Honda H, Feril LB Jr, Kudo N, Kondo T (2006) Comparison between sonodynamic effect and photodynamic effect with photosensitizers on free radical formation and cell killing. Ultrason Sonochem 13:535–542
Hiroishi K, Eguchi J, Toshiyuki B, Shimazaki T, Ishii S, Hiraide A, Sakaki M, Doi H, Uozomi S, Omori R, Matsumura T, Yanagawa T, Ito T, Imawari M (2010) Strong CD8+ T-cell responses against tumor-associated antigens prolong the recurrence-free interval after tumor treatment in patients with hepatocellular carcinoma. J Gastroenterol 45:451–458
Holohan C, Van Schaeybroeck S, Longley DB, Johnston PG (2014) Cancer drug resistance: an evolving paradigm. Nat Rev Cancer 13:714–726
Hsieh YJ, Wu CC, Chang CJ, Yu JS (2003) Subcellular localization of Photofrin® determines the death phenotype of human epidermoid carcinoma A431 cells triggered by photodynamic therapy: when plasma membranes are the main targets. J Cell Physiol 194:363–375
Huang Z, Moseley H, Bown S (2010) Rationale of combined PDT and SDT modalities for treating cancer patients in terminal stage: the proper use of photosensitizer. Integr Cancer Ther 9:317–319
Huang X, Yuan F, Liang M, Lo HW, Shinohara ML, Robertson C, Zhong P (2012) M-HIFU inhibits tumor growth, suppresses STAT3 activity and enhances tumor specific immunity in a transplant tumor model of prostate cancer. PLoS One 7, e41632
Jeong EJ, Seo SJ, Ahn YJ, Choi KH, Kim KH, Kim JK (2012) Sonodynamically induced antitumour effects of 5-aminolevulinic acid and fractionated ultrasound irradiation in an orthotopic rat glioma model. Ultrasound Med Biol 38:2143–2150
Kawabata K, Umemura S (1997) Xanthene dyes for reducing acoustic cavitation threshold in aqueous solution. Ultrasonics 35:469–474
Kenyon JN, Fulle RJ, Lewis TJ (2009) Activated cancer therapy using light and ultrasound – a case series of sonodynamic photodynamic therapy in 115 patients over a 4 year period. Curr Drug Ther 4:179–193
Kessel D, Vicente MG, Reiners JJ (2006) Initiation of apoptosis and autophagy by photodynamic therapy. Lasers Surg Med 38:482–488
Kolarova H, Tomankova K, Bajgar R, Kolar P, Kubinek R (2009) Photodynamic and sonodynamic treatment by phthalocyanine on cancer cell lines. Ultrasound Med Biol 35:1397–1404
Komori C, Okada K, Kawamura K, Chida S, Suzuki T (2009) The sonodynamic antitumor effect of methylene blue on sarcoma180 cells in vitro. Anticancer Res 29:2411–2416
Kondo Y, Kanzawa T, Sawaya T, Kondo S (2005) The role of autophagy in cancer development and response to therapy. Nat Rev Cancer 5:726–734
Kuroki M, Hachimine K, Abe H, Shibaguchi H, Kuroki M, Maekawa S, Yanagisawa J, Kinugasa T, Tanaka T, Yamashita Y (2007) Sonodynamic therapy of cancer using novel sonosensitisers. Anticancer Res 27:3673–3678
Li JH, Song DY, Xu YG, Huang Z, Yue W (2008a) In vitro study of hematoporphyrin monomethyl ether-mediated sonodynamic effects on C6 glioma cells. Neurol Sci 29:229–235
Li YS, Reid CN, McHale AP (2008b) Enhancing ultrasound-mediated cell membrane permeabilisation (sonoporation) using a high frequency pulse regime and implications for ultrasound-aided cancer chemotherapy. Cancer Lett 266:156–162
Li Y, Wang P, Zhao P, Zhu S, Wang X, Liu Q (2012) Apoptosis induced sonodynamic treatment by protoporphyrin IX MDA-MB-231 cells. Ultrasonics 52:490–496
Li D, Kang J, Madoff DC (2014a) Locally ablative therapies for primary and metastatic liver cancer. Expert Rev Anticancer Ther 14:931–945
Li Q, Liu Q, Wang P, Feng X, Wang H, Wang X (2014b) The effects of Ce6-mediated sono-photodynamic therapy on cell migration, apoptosis and autophagy in mouse mammary 4T1 cell line. Ultrasonics 54:981–989
Li Y, Wang P, Wang X, Su X, Liu Q (2014c) Involvement of mitochondrial and reactive oxygen species in the sonodynamic toxicity of chlorin e6 in human leukemia K562 cells. Ultrasound Med Biol 40:990–1000
Liu S, Kurzrock R (2014) Toxicity of targeted therapy: implications for response and impact of genetic polymorphisms. Cancer Treat Rev 40:883–891
Liu QH, Wang XB, Wang P, Xiao L, Hao Q (2007) Comparison between sonodynamic effect with protoporphyrin IX and hematoporphyrin on sarcoma 180. Cancer Chemother Pharmacol 60:671–680
Macdonald IJ, Dougherty TJ (2001) Basic principles of photodynamic therapy. J Porphyrins Phthalocyanines 5:105–129
Master A, Livingston M, Sen Gupta A (2013) Potodynamic nanomedicine in the treatment of solid tumors: perspectives and challenges. J Control Release 168:88–102
McCaughan B, Rouanet C, Fowley C, Nomikou N, McHale AP, McCarron PA, Callan JF (2011) Enhanced ROS production and cell death through combined photo- and sono-activation of conventional photosensitising drugs. Bioorg Med Chem Lett 21:5750–5752
McEwan C, Owen J, Stride E, Fowley C, Nesbitt H, Cochrane D, Coussios Constantin. C, Borden M, McHale AP, Callan JF (2015) Oxygen carrying microbubbles for enhanced sonodynamic therapy of hypoxic tumours. J Controlled Release 203:51–56
Meng Y, Zou C, Madiyalakan R, Woo T, Huang M, Yang X, Swanson E, Chen J, Xing JZ (2010) Water-soluble and biocompatible sono/photosensitizer nanoparticles for enhanced cancer therapy. Nanomedicine 5:1559–1569
Misik V, Riesz P (2000) Free radical intermediates in sonodynamic therapy. Ann N Y Acad Sci 899:335–348
Miyoshi N, Igarashi T, Riesz P (2000) Evidence against singlet oxygen formation by sonolysis of aqueous oxygen-saturated solutions of hematoporphyrin and rose bengal. The mechanism of sonodynamic therapy. Ultrason Sonochem 7:121–124
Moan J, Berg K (1991) The photodegradation of porphyrins in cells can be used to estimate the lifetime of singlet oxygen. Photochem Photobiol 53:549–553
Mokuyasu S, Suzuki Y, Kawahara E, Seto T, Tokuda Y (2014) High-sensitivity cardiac troponin I detection for 2 types of drug-induced cadiotoxicity in patients with breast cancer. Breast Cancer (in press) DOI: 10.1007/s12282-014-0520-8
Moseley H, Eljamel S Moghissi K (2014) Sonodynamic therapy. http://www.yorkshirelasercentre.org/index.php/sonodynamic-therapy. Accessed 26 June 2014
Narang AS, Varia S (2011) Role of tumor vascular architecture in drug delivery. Adv Drug Deliv Rev 63:640–658
Ni Y, Mulier S, Miao Y, Michel L, Marchal G (2005) A review of the general aspects of radiofrequency ablation. Abdom Imaging 30:381–400
Nishikawa H, Osaki Y (2013) Comparison of high-intensity focused ultrasound therapy and radiofrequency ablation for recurrent hepatocellular carcinoma. Hepatobiliary Surg Nutr 2:168–170
Nomikou N, Li YS, McHale AP (2010) Ultrasound-enhanced drug dispersion through solid tumours and its possible role in aiding ultrasound-targeted cancer chemotherapy. Cancer Lett 288:94–98
Nomikou N, Fowley C, Byrne NM, McCaughan B, McHale AP, Callan JF (2012a) Microbubble-sonosensitiser conjugates as therapeutics in sonodynamic therapy. Chem Commun 48:8332–8334
Nomikou N, Sterrett C, Arthur C, McCaughan B, Callan JF, McHale AP (2012b) The effects of ultrasound and light on indocyanine-green-treated tumour cells and tissues. ChemMedChem 7:1465–1471
Nonaka M, Yamamoto M, Yoshino S, Umemura S, Sasaki K, Fukushima T (2009) Sonodynamic therapy consisting of focused ultrasound and a photosensitiser causes a selective antitumor effect in a rat intracranial glioma model. Anticancer Res 29:943–950
Ohmura T, Fukushima T, Shibaguchi H, Yoshizawa S, Inoue T, Kuroki M, Sasaki K, Umemura S (2011) Sonodynamic therapy with 5-aminolevulinic acid and focused ultrasound for deep-seated intracranial glioma in rat. Anticancer Res 31:2527–2534
Osaki T, Tajima M, Okamoto Y, Takagi S, Tsuka T, Imagawa T, Minami S (2011) Sonodynamic antitumor effect of benzoporphyrin derivative monoacid ring a on KLN205 cells. J Cancer Ther 2:99–104
Pickworth MJW, Dendy PP, Leighton TG, Twentyman PR (1988) Studies of the cavitational effects of clinical ultrasound by sonolumenescence: 2. Thresholds for sonoluminescence from a therapeutic ultrasound beam and the effect of temperature and duty cycle. Phys Med Biol 33:1249–1260
Ren Y, Wang R, Liu Y, Guo H, Zhou X, Yuan X, Liu C, Tian J, Yin H, Wang Y, Zhang N (2014) A hematoporphyrin-based drug delivery system for drug resistance reversal and tumor ablation. Biomaterials 35:2462–2470
Roberts D, Cairnduff F, Driver I, Dixon B, Brown S (1994) Tumor vascular shutdown following photodynamic therapy based on polyhematoporphyrin or 5-aminolevulinic acid. Int J Oncol 5:763–768
Rodriguez N, Sanz X, Dengra J, Foro P, Membrive I, Reig A, Quera J, Fernandez-Velilla E, Pera O, Lio J, Lozano J, Algara M (2013) Five-year outcomes, cosmesis and toxicity with 3-dimensional conformal external beam radiation therapy to deliver accelerated partial breast irradiation. Int J Radiat Oncol Biol Phys 87:1051–1057
Rosenthal I, Sostaric JZ, Riesz P (2004) Sonodynamic therapy – a review of the synergistic effects of drugs and ultrasound. Ultrason Sonochem 11:349–363
Saksena TK, Nyborg WL (1970) Sonoluminescence from stable cavitation. J Chem Phys 53:1722–1733
Sazgarnia A, Shanei A, Meibodi NT, Eshghi H, Nassirli H (2011) A novel sonosensitizer for sonodynamic therapy: in vivo study on a colon tumor model. J Ultrasound Med 30:1321–1329
Sazgarnia A, Shanei A, Eshghi H, Hassanzadeh-Khayyat M, Esmaily H, Shanei MM (2013) Detection of sonoluminescence signals in a gel phantom in the presence of protoporphyrin IX conjugated to gold nanoparticles. Ultrasonics 53:29–35
Sciacovelli M, Gaude E, Hilvo M, Frezza C (2014) The metabolic alterations of cancer cells. Methods Enzymol 542:1–23
Shanei A, Sazgarnia A, Meibodi N, Hassanzadeh-Khayyat M, Esmaily H, Attaran Kakhki N (2012) Sonodynamic therapy using protoporphyrin IX conjugated to gold nanoparticles: an in vivo study on a colon tumor model. Iran J Basic Med Sci 15:759–767
Shi H, Liu Q, Qin X, Wang P, Wang X (2011) Pharmacokinetic study of a novel sonosensitizer chlorin-e6 and its sonodynamic anti-cancer activity in hepatoma-22 tumor-bearing mice. Biopharm Drug Dispos 32:319–332
Siemann DW (2011) The unique characteristics of tumour vasculature and preclinical evidence for its selective disruption of tumour-vascular disrupting agents. Cancer Treat Rev 37:63–74
Starkey JR, Rebane AK, Drobizhev MA, Meng F, Gong A, Elliot A, McInnerney K, Splangler CW (2008) New two-photon activated photodynamic therapy sensitizers induce xenograft tumor regressions after near-IR laser treatment though the body of the host mouse. Clin Cancer Res 14:6564–6573
Stepniewski M, Kepczynski M, Jamroz D, Nowakowska M, Rissanen S, Vattulainen I, Rog T (2012) Interaction of hematoporphyrin with lipid membranes. J Phys Chem B 116:4889–4897
Sugita N, Kawabata K, Sasaki K, Sakata I, Umemura S (2007) Synthesis of amphiphilic derivatives of rose bengal and their tumor accumulation. Bioconjug Chem 18:866–873
Sugita N, Iwase Y, Yumita N, Ikeda T, Umemura S (2010) Sonodynamically induced cell damage using rose bengal derivative. Anticancer Res 30:3361–3366
Suzuki N, Okada K, Chida S, Komori C, Shimada Y, Suzuki T (2007) Antitumor effect of acridine orange under ultrasonic irradiation in vitro. Anticancer Res 27:4179–4184
Tachibana K, Feril LB, Ikeda-Dantsuji Y (2008) Sonodynamic therapy. Ultrasonics 24:253–259
Tang W, Liu Q, Wang X, Mi N, Wang P, Zhang J (2008) Membrane fluidity altering and enzyme inactivating in sarcoma 180 cells post the exposure to sonoactivated hematoporphyrin in vitro. Ultrasonics 48:66–73
Tang W, Liu Q, Wang X, Wang P, Zhang J, Cao B (2009) Potential mechanism in sonodynamic therapy and focused ultrasound induced apoptosis in sarcoma 180 cells in vitro. Ultrasonics 49:86–793
Tonder M, Eisele G, Weiss T, Hofer Sm Seystahl K, Valavanis A, Stupp R, Weller M, Roth P (2014) Addition of lomustine for bevacizumab-refractory recurrent glioblastoma. Acta Oncol 26:1–4
Torchilin V (2001) Tumor delivery of macromolecular drugs based on the EPR effect. Adv Drug Deliv Rev 63:131–135
Tran Cao HS, Lopez N, Chang DC, Lowy A, Bouvet M, Baumgartner JM, Talamini MA, Sicklick JK (2014) Improved perioperative outcomes with minimally invasive distal pancreatectomy: results from a population-based study. JAMA Surg 149:237–243
Tserkovsky DA, Alexandrova EN, Chalau VN, Istomin YP (2012) Effects of combined sonodynamic and photodynamic therapies with photolon on a glioma C6 tumor model. Exp Oncol 34:332–335
Umemura S, Yumita N, Nishigaka R, Umemura K (1990) Mechanism of cell damage by ultrasound in combination with hematoporphyrin. Jpn J Cancer Res 81:962–966
Umemura S, Kawabata K, Nishigaki R, Umemura K (1992) Sonodynamic approach to tumor treatment. Proc IEEE Ultrason Symp 9:1231–1240
Umemura S, Yumita N, Umemura K, Nishigaki R (1999) Sonodynamically induced effect of rose bengal on isolated sarcoma 180 cells. Cancer Chemother Pharmacol 43:389–393
Wang X, Lewis TJ, Mitchell D (2008) The tumoricidal effect of sonodynamic therapy (SDT) on S-180 sarcoma in mice. Integr Cancer Ther 7:96–102
Wang X, Zhang W, Xu Z, Luo Y, Mitchell D, Moss RW (2009) Sonodynamic and photodynamic therapy in advanced breast carcinoma: a report of 3 cases. Integr Cancer Ther 8:283–287
Wang X, Liu Q, Wang Z, Wang P, Zhao P, Zhao X, Yang L, Li Y (2010) Role of autophagy in sonodynamic therapy-induced cytotoxicity in S180 cells. Ultrasound Med Biol 36:1933–1946
Wrenn SP, Small E, Dan N (2013) Bubble nucleation in lipid bilayers: a mechanism for low frequency ultrasound disruption. Biochim Biophys Acta 1828:1192–1197
Xiang J, Xia X, Leung AW, Wang X, Xu J, Wang P, Yu H, Bai D, Xu C (2011) Apoptosis of ovarian cancer cells induced by methylene blue-mediated sonodynamic action. Ultrasonics 1:390–395
Xu ZY, Wang K, Li XQ, Chen S, Deng JM, Cheng Y, Wang ZG (2013) The ABCG2 transporter is a key molecular determinant of the efficacy of sonodynamic therapy with Photofrin in glioma stem-like cells. Ultrasonics 53:232–238
Yoshino SI, Fukushima T, Hayashi S, Nanola M, Ogawa K, Sasaki K, Umemura S (2009) Effects of focused ultrasound sonodynamic treatment on the rat blood-brain barrier. Anticancer Res 29:889–896
Yumita N, Umemura S (2004a) Sonodynamic antitumour effect of chloroaluminum phthalocyanine tetrasulfonate on murine solid tumor. J Pharm Pharmacol 56:85–90
Yumita N, Umemura S (2004b) Ultrasonically induced cell damage and membrane lipid peroxidation by photofrin II: mechanism of sonodynamic activation. J Med Ultrason 31:35–40
Yumita N, Nishigaki R, Umemura K, Umemura S (1989) Hematoporphyrin as a sensitizer of cell-damaging effect of ultrasound. Jpn J Cancer Res 80:219–222
Yumita N, Nishigaki R, Umemura K, Umemura S (1990) Synergistic effect of ultrasound and hematoporphyrin on sarcoma 180. Jpn J Cancer Res 81:304–308
Yumita N, Sasaki K, Umemura S, Nishigaki R (1996) Sonodynamically induced antitumor effect of a gallium-porphyrin complex, ATX-70. Jpn J Cancer Res 87:310–316
Yumita N, Okuyama N, Sasaki K, Umemura S (2007) Sonodynamic therapy on chemically induced mammary tumor: pharmacokinetics, tissue distribution and sonodynamically induced antitumor effect of gallium-porphyrin complex ATX-70. Cancer Chemother Pharmacol 60:891–897
Yumita N, Han QS, Kitazumi I, Umemura S (2008) Sonodynamically-induced apoptosis, necrosis, and active oxygen generation by mono-l-aspartyl chlorin e6. Cancer Sci 99:166–172
Yumita N, Iwase Y, Nishi K, Ikeda T, Umemura S, Sakata I, Momose Y (2010) Sonodynamically induced cell damage and membrane lipid peroxidation by novel porphyrin derivative, DCPH-P-Na (I). Anticancer Res 30:2241–2246
Zheng L, Sun X, Zhu X, Lv F, Zhong Z, Zhang F, Guo W, Cao W, Yang L, Tian Y (2014) Apoptosis of THP-1 derived macrophages induced by sonodynamic therapy using a new sonosensitizer hydroxyl acetylated curcumin. PLoS One 9, e93133
Zhu B, Liu Q, Want Y, Wang X, Wang P, Zhang L, Su S (2010) Comparison of accumulation, subcellular location and sonodynamic cytotoxicity between hematoporphyrin and protoporphyrin IX in L1210 cells. Chemotherapy 56:403–410
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
McHale, A.P., Callan, J.F., Nomikou, N., Fowley, C., Callan, B. (2016). Sonodynamic Therapy: Concept, Mechanism and Application to Cancer Treatment. In: Escoffre, JM., Bouakaz, A. (eds) Therapeutic Ultrasound. Advances in Experimental Medicine and Biology, vol 880. Springer, Cham. https://doi.org/10.1007/978-3-319-22536-4_22
Download citation
DOI: https://doi.org/10.1007/978-3-319-22536-4_22
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-22535-7
Online ISBN: 978-3-319-22536-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)